ArticleDiabetes, obesity & metabolism2026

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.

Koutaro Yokote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.